ARTICLE | Clinical News
Borean preclinical data
December 12, 2005 8:00 AM UTC
In a transgenic mouse model of RA a TNF alpha antagonist significantly reduced disease progression and was equivalent to Remicade compared to control. The tumor necrosis factor (TNF) alpha antagonis...